Abstract
Cavrotolimod, a Nanoparticle Toll-like Receptor 9 Agonist, Inhibits Tumor Growth and Alters Immune Cell Composition in Mouse Models of Skin Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have